The investment interest comes as Indian drugmakers are focusing on specialty products, while relying extensively on Chinese imports for basic ingredients and other raw materials used in medicines
Promeet Ghosh (right), deputy head of Temasek India, and R Venkatesh (LEFT), managing director speak to Jash Kriplani
Innoven Capital is a pioneer in venture debt and market leader in India
Investment will be used to expand Indian operations, acquire latest technology for super specialty eye care; firm plans to double number of hospitals to 150, treble turnover to Rs 1,500 crore
Temasek India is bullish on consumption stories
TPG Growth is the middle market and growth equity investment platform of global alternative asset firm TPG
It started investing outside Singapore in 2002-03